secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2025-10-16T23:59:59+00:00
Accession:  0001683168-25-007586
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical (AEMD) files 1-for-10 reverse stock split effective Oct 16, 2025; split-adjusted trading Oct 20
--------------------------------------------------------------------------------

- Reverse split effective 10:00 a.m. ET Oct 16, 2025; split-adjusted trading begins Oct 20 under symbol AEMD.
- Authorized shares reduced from 60M to 6M; outstanding shares from ~7.6M to ~761k (no fractional shares, rounding up).
- Split intended to maintain Nasdaq Listing Rule 5550(a)(2) compliance and manage dilution.
- No stockholder approval required under Nevada law; board approved per NRS Section 78.207.
- CUSIP changes to 00808Y604; Computershare as transfer agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316825007586/0001683168-25-007586-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316825007586/aemd_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-007586

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer